More Evidence for Oxaliplatin as Colon Cancer Chemotherapy (HealthDay)

Your Health Matters

HealthDay – FRIDAY, Jan. 20 (HealthDay News) — Adding oxaliplatin to a
standard chemotherapy regimen boosts survival rates for patients with
advanced colon cancer, according to a new study that bolsters previous
research on the drug by looking at a broader group of patients.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave